Technical Analysis for 0GRZ - RaySearch Laboratories AB ser. B
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| A | 120.60 | 0.17% | 0.20 |
Earnings due: May 17
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Support | Bullish | 0.00% | |
| Hammer Candlestick | Bullish | 0.00% | |
| New 52 Week Closing High | Bullish | 0.00% | |
| Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
| Expansion Breakout | Bullish Swing Setup | 0.00% | |
| Reversal New Highs Setup | Bullish Swing Setup | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| Doji - Bullish? | Reversal | 0.00% | |
| New 52 Week High | Strength | 0.00% |
Get a Trading Sidekick!
RaySearch Laboratories AB ser. B Description
RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment in the Asia-Pacific, the Middle East, the Americas, Europe, and Africa. It develops and markets RayStation, a treatment planning system; RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information. In addition, it offers µ-RayStation, a software platform for planning and evaluation in small animal irradiation research; RayCommand, a treatment control system that serves as link between the treatment machine and the treatment planning and oncology information systems; and RayIntelligence, a cloud-based oncology analytics system that turns patient data into insights. Further, the company provides training courses related to its products. RaySearch Laboratories AB (publ) is headquartered in Stockholm, Sweden.
Classification
Keywords: Health Medicine Cancer Software Solutions Branches Of Biology Oncology Medical Technology Software Platform Radiation Medical Physics Radiation Therapy Radiobiology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 120.6 |
| 52 Week Low | 41.1 |
| Average Volume | 8,276 |
| 200-Day Moving Average | 70.25 |
| 50-Day Moving Average | 80.37 |
| 20-Day Moving Average | 89.15 |
| 10-Day Moving Average | 105.37 |
| Average True Range | 15.59 |
| RSI (14) | 82.49 |
| ADX | 38.27 |
| +DI | 17.84 |
| -DI | 3.52 |
| Chandelier Exit (Long, 3 ATRs) | 73.84 |
| Chandelier Exit (Short, 3 ATRs) | 103.86 |
| Upper Bollinger Bands | 129.38 |
| Lower Bollinger Band | 48.92 |
| Percent B (%b) | 0.89 |
| BandWidth | 90.26 |
| MACD Line | 11.83 |
| MACD Signal Line | 7.77 |
| MACD Histogram | 4.0562 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 177.15 | ||||
| Resistance 3 (R3) | 170.87 | 145.73 | 167.73 | ||
| Resistance 2 (R2) | 145.73 | 131.33 | 148.88 | 164.58 | |
| Resistance 1 (R1) | 133.17 | 122.43 | 139.45 | 139.45 | 161.44 |
| Pivot Point | 108.03 | 108.03 | 111.18 | 111.18 | 108.03 |
| Support 1 (S1) | 95.47 | 93.63 | 101.75 | 101.75 | 79.76 |
| Support 2 (S2) | 70.33 | 84.73 | 73.48 | 76.62 | |
| Support 3 (S3) | 57.77 | 70.33 | 73.48 | ||
| Support 4 (S4) | 64.05 |
